Despite the desirable advancement in synthesizing transition-metal phosphides (TMPs)-based hybrid structures, most methods depend on foreign-template-based multistep procedures for tailoring the specific structure. Herein, a self-template and recrystallization-self-assembly strategy for the one-step synthesis of core-shell-like cobalt phosphide (CoP) nanoparticles embedded into nitrogen and phosphorus codoped porous carbon sheets (CoP⊂NPPCS), is first proposed. Relying on the unusual coordination ability of melamine with metal ions and the cooperative hydrogen bonding of melamine and phytic acid to form a 2D network, a self-synthesized single precursor can be attained. Importantly, this approach can be easily expanded to synthesize other TMPs⊂NPPCS. Due to the unique compositional and structural characteristics, these CoP⊂NPPCSs manifest outstanding electrochemical performances as anode materials for both lithium- and potassium-ion batteries. The unusual hybrid architecture, the high specific surface area, and porous features make the CoP⊂NPPCS attractive for other potential applications, such as supercapacitors and electrocatalysis.
Surface tension, fluorescence, and circular dichroism (CD) methods have been used to investigate the interaction between cationic gemini surfactant 1,2-ethane bis(dimethyldodecylammonium bromide) (C12C2C12) and proteins including bovine serum albumin (BSA) and gelatin. Surface tension measurements show that the complexes of gelatin--C12C2C12 form more easily than that of BSA--C12C2C12. Addition of C12C2C12 has a different effect not only on the polarity of the microenvironment in BSA and gelatin systems but also on their fluorescence spectra. It can be seen from far-UV CD spectra that the alpha-helical network of BSA is disrupted and its content decreases from 41.7% to 27.6% while the random coil content of gelatin increases from 53.0% to 55.9% with increasing C12C2C12 concentration. The results from near-UV CD spectra show that the binding of C12C2C12 induces changes of the microenvironment around the aromatic amino acid residues and disulfide bonds of BSA at high C12C2C12 concentrations.
The intricate charge–discharge reactions and bad conductivity nature of sulfur determine the extreme importance of cathode engineering for Li–S batteries. Herein, spinel ZnCo2O4 porous particles@N‐doped reduced graphene oxide (ZnCo2O4@N‐RGO) are prepared via the combined procedures of refluxing and hydrothermal treatment, consisting of interconnected uniform ZnCo2O4 nanocubes with an average size of 5 nm anchored on graphene nanosheets. The as‐obtained composite can act as an inimitable cathode scaffold to suppress the shuttling of polysulfides by chemical confinement of ZnCo2O4 and N‐RGO for the first time, as demonstrated by the adsorption energy of ZnCo2O4 to Li2S4 via the strong chemical bonding between Zn or Co and S. The RGO nanosheets with a relatively high specific surface area provide a good conductive network and structural stability. The introduction of doped N atoms and numerous ZnCo2O4 porous nanoparticles can inhibit the transfer of lithium polysulfides between the cathode and anode. Due to the unique structural and compositional features, the as‐obtained hybrid materials with the high sulfur loading of 71% and even 82% still deliver high specific capacity, good rate capability, and enhanced cycling stability with exceptionally high initial Coulombic efficiency, which displays a high utilization of sulfur.
CTLA-4 is a negative regulator of the proliferation and the effector function of T-cells. Therefore, it might be important to determine its expression on tumor cells and T-lymphocytes from cancer patients, to investigate its role in initiating and maintaining the neoplastic pathogenesis. CTLA-4 expression was detected in breast tissue by immunohistochemical staining and RT-PCR in 60 patients with breast cancer and 30 normal controls. The levels of CTLA-4 on T lymphocytes in 33 of the patients and 27 of the control group were determined by flow cytometry. Isolated peripheral blood mononuclear cells (PBMCs) were stimulated with phytohaemagglutinin (PHA). Stimulation index and IL-2 level in the cell culture supernatant were measured by MTT assay and ELISA method, respectively. Patients showed strong expression of CTLA-4 in the tumor cells of all specimens at both the protein and mRNA level, but only weakly positive or negative expression in normal breast tissue. Patients with higher mRNA level of CTLA-4 had obvious axillary lymph nodes metastases and higher clinical stage. Spontaneous expression of CD3 CTLA-4 on PBMCs of tumor patients was also significantly higher than that of the controls. Moreover, PBMCs derived from patients with high expression of CD3 CTLA-4 T-cells showed poor responsiveness to PHA stimulation and lower IL-2 production. Therefore, abnormal expression and dysregulation of CTLA-4 could partly explain the mechanism of evasion of anti-tumor immune responses in breast cancer patients and therefore highlight its importance in the development and progression of breast cancer.
Lithium metal has been regarded as an ideal anode material for high-energy-density batteries.
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), a potent immunoregulatory molecule, can down-regulate T-cell activation and inhibit anti-tumor immune response. This study showed that LPS-stimulated human dendritic cells (DCs) decreased the expression of HLA-DR, CD83 and costimulatory molecules (CD40, CD80 and CD86) following coculturing with CTLA-4+ breast cancer cells. Moreover, the suppressed DCs further inhibited proliferation of allogeneic CD4+/CD8+ T-cells, differentiation of Th1 and function of cytotoxic lymphocytes (CTLs). However, CTLA-4 blockade in breast cancer cells could recover DC maturation and cytokine production, elevate antigen-presenting function of DCs, reverse Th1/CTLs response and cytokine secretion. Subsequent study demonstrated that the activation of extracellular-signal regulated kinase and signal transducer and activator of transcription 3 of DCs caused by CTLA-4+ breast cancer cells were the predominant mechanism of DC suppression. In addition, CTLA-4 blockade treatment also directly inhibited proliferation and induced apoptosis of CTLA-4+ breast cancer cells. Collectively, CTLA-4 was expressed and functional on human breast cancer cells through influencing maturation and function of DCs in vitro, and CTLA-4 blockage not only recovered the antigen-presenting function of DCs and T-cells activation but also suppressed the biological activity of breast cancer cells themselves. This study highlights the clinical application of CTLA-4 blockade therapy in breast cancer.
During pregnancy, trophoblast cells sustain the maternal–fetal tolerance via expressing and secreting various chemokines and cytokines. Our previous study revealed the expression of interleukin-35 (IL-35) in human first-trimester trophoblasts. Here we show that IL-35 is expressed in both human first-trimester primary trophoblast cells and a trophoblast cell line. Trophoblast cells inhibit the proliferation of human naive conventional T cells (Tconv cells) and convert suppressed Tconv cells into iTR35 in an IL-35-dependent manner. Mechanistically, trophoblast cell derived IL-35 mediates its function through phosphorylation of STAT1 and STAT3. In vivo studies confirm that mice with immunologically spontaneous abortion have lower levels of IL-35 and iTR35 cells at the maternal–fetal interface, and neutralizing anti-IL-35 mAb enhances abortion rates. Meanwhile, exogenous IL-35 induces iTR35 and prevents immunological abortion. Our findings thus suggest that trophoblast cells have a critical function in preserving maternal–fetal tolerance via secreting IL-35 during pregnancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.